Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen to Restate Loss for Q1 2008

NEW YORK (GenomeWeb News) – Nanogen disclosed in a regulatory filing with the US Securities and Exchange Commission today that it will restate its net loss for the first quarter of 2008 due to an accounting error.
 
As a result of the restatement, Nanogen’s net loss for the quarter ended March 31 will be $26.4 million rather than the $23 million it previously recorded.
 
The error relates to the application of an anti-dilution adjustment of warrants connected to a convertible note offering that was restructured at the end of the first quarter, said Nanogen. The firm said that the non-cash adjustment affects only its results from the first quarter.
 
 
The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.